Is Skeletal Muscle Dysfunction a Limiting Factor of Exercise Functional Capacity in Patients with Sickle Cell...

Area of Science:

• Exercise physiology
• Hematology
• Genetics

Background:

• Sickle cell disease (SCD) is associated with reduced functional capacity, potentially due to anemia, cardio-respiratory issues, and muscle dysfunction.
• The interplay between exercise capacity and muscle function in SCD remains unclear.

Purpose of the Study:

• To investigate the relationship between muscle dysfunction and reduced functional capacity in patients with sickle cell anemia (SCD).
• To determine if muscle dysfunction contributes to exercise limitations in SCD.

Main Methods:

• Compared functional capacity and muscle function in healthy subjects (AA) versus SCD patients (SS and SC).
• Measured maximal isometric torque (Tmax) and electromyography (EMG) of Vastus Lateralis before and after a 6-minute walk test (6-MWT).
• Utilized multiple linear regression to identify predictors of 6-MWT distance.

Main Results:

• SCD patients (SS and SC) exhibited significantly shorter 6-MWT distances compared to healthy controls (AA).
• No significant changes in Tmax or EMG activity were observed post-6-MWT, indicating a lack of skeletal muscle fatigue in any group.
• Genotype, step frequency, and hematocrit independently predicted 6-MWT distance in SCD patients.

Conclusions:

• Reduced 6-MWT performance in SCD is primarily linked to anemia and a self-paced, slower walking cadence, likely a strategy to minimize metabolic cost and fatigue.
• The findings suggest that muscle dysfunction does not explain the exercise limitations observed in SCD patients; rather, compensatory mechanisms related to anemia and gait are key.